{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:58:15Z","timestamp":1792205895778,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biopha.2021.111674","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T06:45:48Z","timestamp":1620629148000},"page":"111674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Dihydrotanshinone I inhibits aortic valve interstitial cell calcification via the SMAD1\/5\/8\/NF-\u03baB\/ERK pathway"],"prefix":"10.1016","volume":"139","author":[{"given":"Yue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaguang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2021.111674_bib1","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/cvr\/cvy245","article-title":"Recent cardiovascular research highlights from China","volume":"115","author":"Gao","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.biopha.2021.111674_bib2","first-page":"e6e24","article-title":"Heart disease and stroke statistics--2013 update: a report from the American Heart Association [published correction appears in Circulation","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"issue":"9540","key":"10.1016\/j.biopha.2021.111674_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2021.111674_bib4","first-page":"284","article-title":"Prevalence and characteristics of unoperated patients with severe aortic stenosis","volume":"20","author":"Bach","year":"2011","journal-title":"J. Heart Valve Dis."},{"issue":"16","key":"10.1016\/j.biopha.2021.111674_bib5","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","article-title":"Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease-2011 update","volume":"124","author":"Rajamannan","year":"2011","journal-title":"Circulation"},{"issue":"11 Suppl 1","key":"10.1016\/j.biopha.2021.111674_bib6","first-page":"S222","article-title":"Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves","volume":"126","author":"Zeng","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2021.111674_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/19768354.2018.1528175","article-title":"Involvement of inflammatory responses in the early development of calcific aortic valve disease: lessons from statin therapy","volume":"22","author":"Lee","year":"2018","journal-title":"Anim. Cells Syst. (Seoul.)"},{"issue":"13","key":"10.1016\/j.biopha.2021.111674_bib8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMe0807001","article-title":"Calcific aortic stenosis--time to look more closely at the valve","volume":"359","author":"Otto","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.111674_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2018.08.029","article-title":"Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease","volume":"277","author":"Cho","year":"2018","journal-title":"Atherosclerosis"},{"issue":"21","key":"10.1016\/j.biopha.2021.111674_bib10","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/eurheartj\/eht034","article-title":"Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation?","volume":"34","author":"Dweck","year":"2013","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.biopha.2021.111674_bib11","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/eurheartj\/ehq237","article-title":"Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation","volume":"31","author":"Hjortnaes","year":"2010","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.biopha.2021.111674_bib12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.ATV.0000227513.13697.ac","article-title":"Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more)","volume":"26","author":"O\u2019Brien","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111674_bib13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/hrt.2007.125740","article-title":"Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis","volume":"94","author":"C\u00f4t\u00e9","year":"2008","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.biopha.2021.111674_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10753-012-9579-6","article-title":"Inflammation is associated with the remodeling of calcific aortic valve disease","volume":"36","author":"Cot\u00e9","year":"2013","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.biopha.2021.111674_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.041","article-title":"Cardiovascular actions and therapeutic potential of tanshinone IIA","volume":"220","author":"Gao","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.111674_bib16","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.2147\/OTT.S204574","article-title":"Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt\/\u03b2-catenin signaling pathway","volume":"12","author":"Tan","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"6","key":"10.1016\/j.biopha.2021.111674_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.vph.2007.01.001","article-title":"Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress","volume":"46","author":"Tang","year":"2007","journal-title":"Vasc. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2021.111674_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.041","article-title":"Cardiovascular actions and therapeutic potential of tanshinone IIA","volume":"220","author":"Gao","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.biopha.2021.111674_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, Regional, and National burden of cardiovascular diseases for 10 causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2021.111674_bib20","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2021.111674_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2017.11.018","article-title":"Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer\u2019s disease","volume":"129","author":"Maione","year":"2018","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.111674_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41569-018-0153-2","article-title":"Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease","volume":"16","author":"Boffa","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111674_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.vph.2007.01.001","article-title":"Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress","volume":"46","author":"Tang","year":"2007","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.biopha.2021.111674_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2017.11.018","article-title":"Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer\u2019s disease","volume":"129","author":"Maione","year":"2018","journal-title":"Pharm. Res."},{"issue":"31","key":"10.1016\/j.biopha.2021.111674_bib25","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/eurheartj\/ehu247","article-title":"Aortic stenosis and coronary artery disease: what do we know? What don\u2019t we know? A comprehensive review of the literature with proposed treatment algorithms","volume":"35","author":"Paradis","year":"2014","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.biopha.2021.111674_bib26","first-page":"182","article-title":"Pathophysiology of aortic valve stenosis: is it both fibrocalcific and sex specific?","volume":"32","author":"Sritharen","year":"2017","journal-title":"Physiol. (Bethesda)"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100456X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100456X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:42:49Z","timestamp":1760100169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100456X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"alternative-id":["S075333222100456X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111674","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydrotanshinone I inhibits aortic valve interstitial cell calcification via the SMAD1\/5\/8\/NF-\u03baB\/ERK pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111674"}}